Neil Goldsmith

Neil Goldsmith is the founder of Biotage AB, founded in 1997.
Mr. Goldsmith was the founder of Evolva SA, founded in 2004, and served as Chief Executive Officer & Director from 2010 to 2017.
Mr. Goldsmith was the founder of EvoNext Holdings SA, founded in 2004, and served as Chief Executive Officer, Director & MD from 2012 to 2017.
Mr. Goldsmith is the founder of Alentis Therapeutics AG, founded in 2019, and served as Chairman from 2019 to 2021.
Mr. Goldsmith is the founder of Sundew ApS, founded in 2018, and serves as Chairman since 2018.
Mr. Goldsmith is also the founder of Topotarget A,Personal Chemistry..
Mr. Goldsmith is Co-Chief Executive Officer at Chosa ApS since 2022.
Mr. Goldsmith is Director at Biotechnology Innovation Organization.
Mr. Goldsmith is Director at Unibio International Plc since 2018.
Mr. Goldsmith is Director at Double Bioventures Ltd. since 2018.
Mr. Goldsmith is Director at Chosa Oncology AB since 2024.
Mr. Goldsmith is Director at Merian Life Sciences ApS.
Mr. Goldsmith was Chief Executive Officer & Director at Allylix, Inc. Mr. Goldsmith was Chief Executive Officer at Auda Pharmaceuticals ApS.
Mr. Goldsmith was Chief Executive Officer at PNA Diagnostics A. Mr. Goldsmith was Chief Executive Officer at GX Biosystems.
A. Mr. Goldsmith was Non-Executive Chairman at InSecta Ltd. Mr. Goldsmith was Director at Quadrant Healthcare Plc.
Mr. Goldsmith was Vice President-Business Development at Biacore AB. Mr. Goldsmith completed undergraduate education at Balliol College.